COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about attendance requirements for live courses and conferences and available COVID-19 online education and resources.
Daiichi Sankyo, Inc. - Exhibitor


 

 

 

 

 

 

 

 

Company Website

Contact Information:

Celina Raider
Cell:  480-201-8798
craider@dsi.com

Candice Bradford
Cell: 480-822-8110
cbradford@dsi.com

 

Virtual Exhibit Hall Home

 

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy.

www.daiichisankyo.us

Iron Deficiency Product Website